UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040555
Receipt number R000046289
Scientific Title Hyperdense artery sign at non-contrast computed tomography reconstructed images for selecting patients for endovascular therapy
Date of disclosure of the study information 2020/05/31
Last modified on 2022/12/04 21:01:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Hyperdense artery sign at non-contrast computed tomography reconstructed images for selecting patients for endovascular therapy

Acronym

HASTE study

Scientific Title

Hyperdense artery sign at non-contrast computed tomography reconstructed images for selecting patients for endovascular therapy

Scientific Title:Acronym

HASTE study

Region

Japan


Condition

Condition

Acute ischemic stroke

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To address the usefulness of hyperdense artery sign at non-conrast computed tomography reconstructed images for selecting acute stroke patients for endovascular therapy

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Door-to-puncture time

Key secondary outcomes

Concordance rate between the site of hyperdense artery sign and occlusion site in digital subtraction angiography
modified Rankin Scale at 90 days
Ischemic stroke recurrence, symptomatic intracranial hemorrhage and death withn 90 days


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

When there is a hyperdense artery sign at non-contrast computed tomography reconstructed images, digital subtraction angiography is immediately performed before acute endovascular therapy. If there is no hyperdense artery sign, additional vascular imaging including carotid duplex ultrasound, MR angiography or CT angiography is considered.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Endovascular treatment can be initiated within 6 hours of symptom onset
NIHSS score of >=6
ASPECTS of >=6
Age>=20 years
Written informed consent is obtained

Key exclusion criteria

Prestroke mRS score>=3
CT not taken at our hospital
Imaging of the previous hospital revealed large vessel occlusion
Endovascular therapy is contraindicated

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Takuya
Middle name
Last name Saito

Organization

Kohnan hospital

Division name

Department of Stroke Neurology

Zip code

9820012

Address

4-20-1 Nagamachi-minami, Taihaku-ku, Sendai 982-8523, Japan

TEL

022-248-2131

Email

tsai10@kohnan-sendai.or.jp


Public contact

Name of contact person

1st name Takuya
Middle name
Last name Saito

Organization

Kohan Hospital

Division name

Department of Stroke Neurology

Zip code

9820012

Address

4-20-1 Nagamachi-minami, Taihaku-ku, Sendai 982-8523, Japan

TEL

022-248-2131

Homepage URL


Email

tsai10@kohnan-sendai.or.jp


Sponsor or person

Institute

Kohan Hospital

Institute

Department

Personal name



Funding Source

Organization

Kohan Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kohnan Hospital Ethics Committee

Address

4-20-1 Nagamachi-minami, Taihaku-ku, Sendai 982-8523, Japan

Tel

022-248-2131

Email

mura919@kohnan-sendai.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 05 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

99

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2020 Year 05 Month 20 Day

Date of IRB

2020 Year 05 Month 20 Day

Anticipated trial start date

2020 Year 06 Month 01 Day

Last follow-up date

2021 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 05 Month 28 Day

Last modified on

2022 Year 12 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046289


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name